A detailed history of Keeley Teton Advisors, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Keeley Teton Advisors, LLC holds 84,725 shares of AXGN stock, worth $1.26 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
84,725
Previous 84,725 -0.0%
Holding current value
$1.26 Million
Previous $613,000 93.64%
% of portfolio
0.14%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$3.61 - $7.76 $175,897 - $378,106
48,725 Added 135.35%
84,725 $578,000
Q3 2023

Nov 08, 2023

BUY
$4.68 - $9.26 $168,480 - $333,360
36,000 New
36,000 $180,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $627M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Keeley Teton Advisors, LLC Portfolio

Follow Keeley Teton Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keeley Teton Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keeley Teton Advisors, LLC with notifications on news.